Search form

Search form

McAfee is debuting a high-throughput intrusion-prevention system, called the NS-Series, which uses Intel technology to provide network-behavior monitoring, an alert system and application awareness. The products will help to protect the data and services now being pushed faster than ever through network pipes, Ellen Messmer writes.

Related Summaries

The Environmental Protection Agency is making progress in shifting its Endocrine Disruptor Screening Program to greater use of computational and high-throughput screening in human cells and use of new androgen and thyroid models. The EPA's toxics chief, Jim Jones, aims to have a model in about a year for replacing some androgen receptor assays in the first tier of the original screening program. The EPA has issued test orders for fewer than 100 chemicals and has screened 52 in the first tier of assays.

The International Council of Chemical Associations has issued 11 recommendations on endocrine disruptors as high-throughput screening tools are allowing better prioritization and faster screening. "By improving screening and testing, we can support evidence-based decision making by regulatory agencies," said American Chemistry Council President and ICCA Council Secretary Cal Dooley. "Chemical manufacturers agree that more research is needed to better understand whether, how and to what effect specific chemicals interact with the endocrine system."

McAfee is debuting a high-throughput intrusion-prevention system, called the NS-Series, which uses Intel technology to provide network-behavior monitoring, an alert system and application awareness. Experts say the products will help protect the data and services now being pushed faster than ever through network pipes.

The Environmental Protection Agency is taking several steps toward prioritized, quicker testing of chemicals for toxicity, including high-throughput in vitro assays. "Our long-term solution is not generating more information faster, but it is really to identify what specific data for which chemicals, which exposures and which populations are essential to assess risk," said John R. Fowle III of the EPA's Office of Pesticide Programs.

The Johns Hopkins Drug Library and other laboratories that collect old medicines are gaining popularity among researchers seeking to find new uses for already approved treatments. With the help of high-throughput screening, an automated technology used in examining experimental compounds, Johns Hopkins and commercial suppliers have experienced a surge in orders of drug samples over the past two years.